Volume 13, Number 8—August 2007
Dispatch
Streptococcus sinensis Endocarditis outside Hong Kong
Ilker Uçkay*
, Peter Rohner*, Ignacio Bolivar†, Béatrice Ninet*, Marina Djordjevic*, Vandack Nobre*, Christian Garzoni*, and Jacques Schrenzel*
, Peter Rohner*, Ignacio Bolivar†, Béatrice Ninet*, Marina Djordjevic*, Vandack Nobre*, Christian Garzoni*, and Jacques Schrenzel*Table
Susceptibility of Streptococcus sinensis–related strain from University Hospitals of Geneva
| Antimicrobial agent | MIC (mg/L) | Interpretation |
|---|---|---|
| Penicillin | 0.064 | Susceptible |
| Ceftriaxone | 0.19 | Susceptible |
| Imipenem | 0.064 | Susceptible |
| Gentamicin | 3 | Intermediate resistant |
| Levofloxacin | 1 | Susceptible |
| Clindamycin | 0.094 | Susceptible |
| Erythromycin | 0.047 | Susceptible |
| Rifampicin | 0.032 | Susceptible |
| Cotrimoxazole | 1 | Susceptible |
| Tetracycline | 0.125 | Susceptible |
| Tigecycline | 0.064 | Susceptible |
| Linezolid | 0.5 | Susceptible |
| Vancomycin | 1 | Susceptible |
| Teicoplanin | 0.25 | Susceptible |
